Pharmabiz

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026: Basel Monday, October 26, 2026, 13:00 Hrs ...
Pharmabiz

CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules

CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules: Gireesh Babu, New Delhi Monday, October 26, 2026, 08:00 Hrs [IST] The Central Drugs Standard C ...
Pharmabiz

India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai

India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai: Nandita Vijayasimha, Bengaluru Monday, October 26, 2026, 08:00 Hrs [IST] India’s dive ...
Pharmabiz

Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects

Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects: Shardul Nautiyal, Mumbai Monday, October 26, 2026, 08:00 Hrs [IST] Maharashtra has recorded an ...
Pharmabiz

JAKs report 8% growth in sales during H1 FY26

The Jan Aushadhi Kendras (JAKs) under the flagship scheme of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) run by the Department of Pharmaceuticals (DoP), has reported a growth of 8% in sales ...
Pharmabiz

Sun Pharma presents long-term follow-up data on Unloxcyt at ESMO 2026

Sun Pharma presents long-term follow-up data on Unloxcyt at ESMO 2026: Our Bureau, Mumbai Monday, October 26, 2026, 12:45 Hrs [IST] Sun Pharmaceutical Industries Limited announced ...
Pharmabiz

Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs

Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs: Peethaambaran Kunnathoor, Chennai Monday, October 26, 2026, 08:00 Hrs [IS ...
Pharmabiz

China NMPA approves Harbour BioMed’s BLA for batoclimab injection to treat generalized myasthenia gravis

China NMPA approves Harbour BioMed’s BLA for batoclimab injection to treat generalized myasthenia gravis: Cambridge, Massachusetts Saturday, October 24, 2026, 17:00 Hrs [IST] Ha ...
Pharmabiz

Labcorp, US FDA and Charles River announce research collaboration to advance preclinical methods for evaluating drug abuse potential

Labcorp, US FDA and Charles River announce research collaboration to advance preclinical methods for evaluating drug abuse potential: Burlington, North Carolina Saturday, October ...
Pharmabiz

Otsuka presents final phase 3 VISIONARY results at ASN demonstrating Voyxact stabilized kidney function and reduced risk of disease progression and kidney failure

Otsuka presents final phase 3 VISIONARY results at ASN demonstrating Voyxact stabilized kidney function and reduced risk of disease progression and kidney failure: Princeton, New ...
Pharmabiz

China approves Enhertu as first and only tumour agnostic HER2 directed medicine and ADC for previously treated patients with HER2 positive metastatic solid tumours

China approves Enhertu as first and only tumour agnostic HER2 directed medicine and ADC for previously treated patients with HER2 positive metastatic solid tumours: Tokyo Saturday ...
Pharmabiz

Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium

Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium: Rahway, New Jersey Saturday ...